Position in ABBV
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$2,699,593
+$1,593,222 QoQ
Shares Held
10,728
+110.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.35%
of 13F equity value
Holder Rank
#1,724
of 4,153 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Trivium Point Advisory, LLC holds $28,456,605 across 8 Drug Manufacturers - General names. ABBV ranks #3 (9.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
13,340 | $16,000,397 | |
| 2 | JNJ |
Johnson & Johnson
|
12,027 | $3,054,497 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
10,728 | $2,699,593 | |
| 4 | MRK |
Merck & Co., Inc.
|
17,671 | $2,270,723 | |
| 5 | AMGN |
Amgen Inc
|
3,478 | $1,259,453 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
20,481 | $1,180,115 | |
| 7 | PFE |
Pfizer Inc
|
45,408 | $1,093,424 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
7,111 | $898,403 |
All Filings in ABBV
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,699,593 | 10,728 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $1,106,371 | 5,087 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $2,356,645 | 10,314 | Shares | Sole | 2026-01-26 | |
| 2025-09-30 | $2,400,375 | 10,367 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $1,940,285 | 10,453 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $2,001,754 | 9,554 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $1,637,150 | 9,213 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $1,823,332 | 9,233 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,887,577 | 11,005 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,217,884 | 6,688 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,056,430 | 6,817 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $998,254 | 6,697 | Shares | Sole | 2023-10-12 | |
| 2023-06-30 | $842,601 | 6,254 | Shares | Sole | 2023-07-13 | |
| 2023-03-31 | $978,850 | 6,142 | Shares | Sole | 2023-04-12 | |
| 2022-12-31 | $287,504 | 1,779 | Shares | Sole | 2023-01-27 | |
| 2022-09-30 | $239,028 | 1,781 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $307,085 | 2,005 | Shares | Sole | 2022-07-27 | |
| 2022-03-31 | $623,637 | 3,847 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $452,777 | 3,344 | Shares | Sole | 2022-02-18 | |
| 2021-09-30 | $306,890 | 2,845 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $308,183 | 2,736 | Shares | Sole | 2021-08-12 | |
| No filing history on record for this holder in this stock. | ||||||